Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
0
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva Test, CoviSafe™
Paul Archie
-
December 8, 2020
0
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
Paul Archie
-
October 20, 2020
0
Biotech News
Home
Biotech News
Page 22
Biotech News
BioSig Technologies Begins Trading on Nasdaq
BiotechStocktrader
-
September 21, 2018
0
Biotech News
BioSig Technologies (BSGM) PT Raised to $12.50 at Chardan Ahead of...
BiotechStocktrader
-
September 20, 2018
0
1
...
20
21
22
Page 22 of 22
- Advertisement -
APPLE
Avivagen Announces Publication of Scientific Paper in British Journal of Nutrition
Andrew M.
-
August 18, 2020
0
Biotech News
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications...
RECENT POSTS
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Paul Archie
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes...
Paul Archie
-
December 15, 2020
Ahead of Vaccine, Fast, Affordable Testing for COVID is Still Essential to Limiting Spread
Paul Archie
-
December 10, 2020
Edit with Live CSS
